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An old twist in HLA-A: CDR3α hook
up at an R65-joint
Joseph S. Murray*
Xenolaüs Genetics LLC, Los Angeles, CA, USA
T-cell ontogeny optimizes the α/β T-cell receptor (TCR) repertoire for recognition of major
histocompatibility complex (MHC) class-I/II genetic polymorphism, and co-evolution of
TCR germline V-gene segments and the MHC must entail somatic diversity generated in
the third complimentary determining regions (CDR3α/β); however, it is still not clear how.
Herein, a conspicuous structural link between the V-Jα used by several different TCR
[all in complex with the same MHC molecule (HLA-A2)], and a conserved MHC motif
(a.a., R65-X-X-K-A-X-S-Q72) is described. We model this R65-joint in detail, and show
that the same TCR’s CDR3α loop maintains its CDR2α loop at a distance of ~4Å from
polymorphic amino acid (a.a.) positions of the α-2 helix in all but one of the analyzed crystal
structures. Indeed, the pitch of docked TCRs varies as their twist/tilt/sway maintains the
R65-joint and peptide contacts. Thus, the R65-joint appears to have poised the HLA-A
lineage toward alloreactivity.
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Introduction
The same DNA-recombinase system (RAG-1/-2) used in B cells for the generation of variants of
the canonical immunoglobulin (Ig) cell-surface receptor is used in T cells to generate a vast diverse
repertoire of T-cell receptor (TCR) variants; these variants of the TCR are clonally distributed on
T cells, as are sIg on B cells (1). By contrast, within any given individual, the number of possible
major histocompatibility complex (MHC) (HLA in human) components of the TCR ligand is limited
by two (at most) different alleles of any given HLA heavy-chain gene (1–3). The most enigmatic
phenomenon involving TCR and the MHC concerns a very high relative frequency of T cells with
exquisite sensitivity to minor changes in the peptide component of pHLA, which nevertheless
proliferate against allogeneic pHLA. Because allo-HLA is not present in the thymus, and as such
the TCR repertoire cannot be selected against different individuals’ HLA molecules, there exists a
high precursor frequency of T cells that cross-react against allo-HLA bearing targets (1–10). Thus,
there is a potent biological capacity in the apparent absence of any stimulus, except during gestation.
Here, we describe how somatically distinct CDR3α (with one exception) achieves a germline-
encoded mean interface of 3.94 0.23Å between CDR2α and a discreet polymorphic region of
HLA-A. Together with bioinformatics evidence, this R65-joint indicates that adaptive immunity is
constrained by an apparent need for precise alloreactivity (11).
Results and Discussion
Shown in Figure 1A is our analysis of the CDR1 and CDR2 contacts made by several distinct
TCR across different TCR:pHLA structures available in the Protein data bank (PDB). All of these
structures involve HLA-A*0201 and each has a distinct peptide component. As can be seen from
the closest contacts made by the TCR, one can classify these TCR as alpha-dominant, alpha/beta,
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FIGURE 1 | (A) CDR1/CDR2 contacts with MHC amino acids among
TCR:pHLA-A2 crystallographic structures. The colors indicate the
alpha-dominant (rose shades), alpha/beta (lavender, green, and yellow),
and beta-dominant (blue) modes of binding. [(B), top] nucleotide
sequences for all CDR3α of TCR in the indicated PDB files. TCRA were
reverse translated then subjected to joint analysis. [(B), bottom] CDR3α
joints (consensus IMGT numbering is shown with PDB numbering as
indicated); contacts were measured with VMD software (www.ks.uiuc.edu).
Characterization of R65 contacts was by analysis of “surf representations”
(i.e., space-filled modeling) as shown in figures below. For multiple
structures involving the same TCR, contacts in one structure are shown,
i.e., for 1AO7 and 2BNQ.
and in one case, beta-dominant, on the basis of these interactions.
Indirectly, this corroborates the role of the CDR3 regions in
selective binding of any given TCR for the peptide component
(12–16). Theoretically, TCR bearing CDR3 regions that did not
disrupt these CDR1/2 interactions with the α-helices of the HLA
groove during fetal life would have been repetitively engaged with
thymic antigen presenting cells, and such clones would be deleted
(1, 4, 9).
Bioinformatics Analysis
Protein data bank files available for TCR:pHLA-A2 solved crystal-
lographic structures (as listed in Figure 1A) were used to obtain
the most likely nucleotide codons of the TCRA chain by reverse
translation using the algorithms available at the SMS.1 Identifica-
tion of Vα and Jα usage (IMGT/V-Quest) and junctional analysis
(IMGT/JunctionAnalysis) among these TCR were performed by
the IMGT algorithms2 and the results are shown in Figure 1B.
Notice, all the CDR3α joints use extensive N-nucleotide additions
(a hallmark of TCRVA somatic DNA rearrangements) to create
a diverse set of amino acid sequences used within the solved
structures. With 54Vα and 61 Jα, TCRVA is unique among anti-
gen receptors, and continuous rearrangement at TCRA ensures
pHLA selects TCR (1). Here, we have undertaken a comprehen-
sive analysis of each of the TCR:pHLA-A2 structures to examine
the contacts made between each CDR3α loop and pHLA-A2 after
we noticed that alpha-dominant, alpha/beta, and beta-dominant
TCR binding all involved CDR3α contact with the MHC. Shown
1http://www.bioinformatics.org
2http://www.imgt.org
in Figures 2A–F is this conspicuous contact that all CDR3αmake
with the α-1 helix of HLA-A2. Note that all CDR3α make closest
contact at the samemotif centered on amino acid (a.a.) R65; 2VLR
is the exception (Figures 2E,F).
R65-Joint
As shown in Figure 2 (compiled in Figure 1B), individual CDR3α
rearrangements lead to structurally distinct types of contact with
the R65 motif, principally, projection-type (dovetail), concave-
type (mortise), or flat-type (dado), all best appreciated with space-
filled models. For example, the dovetail joint of the A6 TCR (in
1AO7, 3PWP, and 3H9S complexes) fits W101 into the compli-
mentary slot made by the side-chains of the R65 motif, i.e., within
the α-helical secondary structure of the α-1 helix (Figures 2A,B).
W101 is located on the lateral side of the CDR3α loop (i.e., the
arm of the parabolic loop that faces away from the groove), and
close contacts with α-1 are mediated by the arm of CDR3α that
faces into the groove, i.e., ~3Å contacts involving salt bridges
(R65NE:D99OD1; R65NH2:T98OG1). Interestingly, the closest
contact with the peptide also involves D99, i.e., Y5OH:D99N
(peptide contacts listed in Figure 1B).
Mortise
Looking further into the R65-motif connections demonstrates the
use of a mortise, i.e., a CDR3α lock for the R65 key. As illus-
trated in Figures 2C,D, this is the most common type of contact
and involves salt bridge formation between an acidic group(s) in
CDR3α and one ormoreNof R65.One such joint involvesN-H-N
contact (dado-type of 304L); also, one of the contacts is shifted
to Q72 by the 3GSN TCR (Figure 1B), and the 2VLR TCR is in
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FIGURE 2 | Representative R65-Joints of these TCR:pMHC.
(A,B) 1AO7; (C,D) 1BD2; (E,F) 2VLR. VMD software used to isolate
structures and make bond measurements; “licorice” representations
are shown at left and “surf” representations are shown on the right.
Docking CDR3α a.a. are in magenta (Vα: in magenta, 1AO7; green,
1BD2; cyan, 2VLR); the R65 motif is in orange, and the H151-A158
region is in green (bottom panels). Peptides are lime, tan, and yellow for
three structures, respectively. Note the W101 dovetail of 1AO7 with
salt-bridges to R65 mediated by the CDR3α loop (A,B). TCR
represented by the 1BD2 file (see Figure 1B) utilizes a concave
mortise, wherein R65 also forms salt bridges. 2VLR’s CDR3α contacts
Q155 in a different strategy (see text).
less contact with α-1 helix (i.e., ~5Å to R65); however, contacts
the α-2 helix via a strikingly congruent mortise involving Q155
(Figures 2E,F). Indeed, 2VLR’s CDR3α seems like an alternative
solution among these structures.
CDR2α/α-2 Helix Interface
The R65-joint is consistent with a range of TCR twist/tilt/sway
(rotations about the plane of the pHLA top face) such that ~4Å
juxtaposition of CDR2α over HLA a.a. 151–158 is achieved
(Figure 3A). Alignment of distant HLA-A alleles with A*0201
(Figure 3B) reveals that H151 of A2 is R151 in A-74, A-31, A-33,
A-29, A-30, A-32, A-23, and A-80. Also, polymorphic is A158 of
A2, which is V158 in A-36 and A-1. Other a.a. 151–158 α-2 poly-
morphisms are not oriented toward the TCR due to the α-helix.
While they might influence allogeneic peptide identity, and thus
indirectly the R65-joint (see below), A158V and H151R clearly
define the interface. Since closer contacts would be expected for
thoseCDR2α contactingA158when the two –CH3 groups replace
two –H on the pos. 158 a.a. Cβ, i.e., V158 (as found in HLA
alleles, A-1 and A-36), and too, H151R could decrease contact
distances (a longer side chain), it follows that all of these TCR
maintain theR65-joint and themarginal contactwith theα-2 helix
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FIGURE 3 | (A) The twist/tilt/sway of TCR-Vα relative to pHLA-A2; PDB files
are denoted for each structure. TCR display a diversity of rotation in-plane
to the groove {twist} with or without rotation perpendicular to the groove
{tilting}; and this includes parallel (side-to-side) variation {sway}. Vα of each
different TCR are colored; Vβ and pHLA-A2 are in cyan. (B) Alignment of
the R65 motif and CDR2α-contact region among HLA-A alleles and
non-human primate MHC A-like proteins. Sequences are from NCBI (blink
analysis) with the HLA-A*0201 sequence as query (www.ncbi.nlm.nih.gov).
(C) NCBI (blast) of HLA-A2 against prosimians taxid; alignment of different
alleles (see text).
by some shared mechanism. Moreover, it leads to an apparent
steric considerationwith respect towhich allotypes are recognized
by a given TCR (see Figure 4).
Conservation
R65-X-X-K-A/G-X-S/A-Q72 is conserved in nearly all primate
MHC A-like molecules (black lemurs are exceptions, with an
A69D disruption; Figure 3B). Interestingly, baboon, rhesus, and
crowned lemur have an A69G substitution, but this would sub-
stantively conserve motif structure. HLA-A24, -23 (as shown)
do not have R65, but interestingly, variants of both do, e.g.,
A*2424, and A*2429. PDB 3W0W (TCR:HIV-1, Nef peptide:A-
2402) has amortise involving CDR3αQ94-G-G-K97 contact with
E62 of the α-1 helix. This shifts the across-the-groove joint, but
the CDR2α/α-2 interface range is maintained (see Figure 6)
in 3W0W, the TCR is more twisted than in any of the HLA-
A2 complexes (see below). More interesting (Figure 3C) is the
apparent disruption of the R65 motif in alleles of Tarsius syrichta
and the colugo, Galeopterus variegatus, as this puts the motif in
a common ancestor (11), some 79.6Mya (Cretaceous), i.e., well
before Paleocene-Eocene, when lemuriforms and tarsiiforms are
thought to have diverged (17, 18).
Role of the Peptide in the R65-Joint
As shown in Figure 5, the peptide contacts CDR3α in a fashion
compatible with the angle between the R65-joint and the poly-
morphic contacts withMHC, viz., the CDR2α/α-2 helix interface.
Within the structures examined here is displayed a consistent
peptide interaction with what could be described as the arm of
the CDR3α loop that faces away from R65. The closest contact of
this nature among the examined complexes is in 3HG1, which is
interesting because this peptide assumes an extended (less bulged)
structure, and the angle between the CDR2α contact residue
(alpha carbon), the R65 alpha carbon, and the α2-helix contact
residue (alpha carbon) (viz., the CDR2α:R65:α-2 angle) is the
largest amongst the structures at 18.90°(Figure 5). Interestingly,
there is no direct correlation between this angle and the closeness
of peptide contact (i.e., whenwe compare all the structures). How-
ever, the CDR2α:R65:α-2 angle does correlate with the overall
orientation of the TCR on pHLA-A. For example, 2BNQ with a
“flat” angle at 12.23° is tilted similarly to 3O4L, but is more twisted
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FIGURE 4 | TCR display interfaces with ~4Å contact at either
A158 (top) or at H151 (bottom). Thus, a steric site opposite (orange
arrow) is available for occupancy by a larger side-chain (~6–7Å).
HLA-A30 (R151) bearing a permissive peptide would be expected to
dock with 3O4L-like TCR, but not 2BNQ-like TCR; HLA-A1 (V158) with
2BNQ-like, but not 3O4L-like TCR. CDR2α and α2-helix (a.a. 151–158)
side chains as stick (left), and space-filled (right); peptides are shown as
space-filled.
than 3O4L (Figure 3A); thus, the lack of “twist” for 3O4L corre-
lates with its increasedR65-angle, 17.96°, as would be the expected
geometry. However, 3QEQ and 3W0W have about the same “tilt,”
but 3W0W is quite more twisted; here, more “twist” correlated
with an increased R65-angle. Therefore, twisting (ω) of the TCR
in the plane of the groove seems dependent on the side-to-side
sway (@) parallel to the groove in its exact relationship to tilting
(λ), i.e., toward the α-1 helix, at least with respect to increasing or
decreasing the R65-angle, or pitch (φ). A plausible formula for the
mechanism, based upon our estimates of these parameters, is the
following (see Figure 6 and Table 1, for compiled data).
kφ = [@  (λ+@)] (ω)
Angles and contacts for PDB files not previously shown:
1AO7: Y50:R65:A158@17.93°, 2BNQ: S53:R65:Q155@12.23°,
4QOK: Y51:R65:A158@19.73°, 3GSN: I52:Q72:A158@17.92°,
4JFD: Y51:R65:A158@21.14°, 3UTT: K102β:R65:H151@24.28°,
and 4EUP: Y52:R65:A158@16.80°.
One testable (19–21) idea is that peptide contacts stabilize
dynamics and the CDR2α/α-2 helix interface. Perhaps, a
“transition state,” involving key TCR interactions with the MHC,
exists initially, followed by peptide interactions with the TCR
being “scanned” in a two-step mechanism (22, 23). Alternatively,
the TCR may “scan-clamp,” where peptide interactions come first
(24–26), or peptide and MHC contacts might occur at the same
time (14). Importantly, the R65-joint mechanism is not incom-
patible with any of these ideas; indeed, different rearrangements
might utilize different dynamics to get to the same structural
geometry.
The corollary that the R65-angle of these obviously selected
TCR reflects deleted (not-selected) thymocytes yielding closer or
more distant CDR2α/α-2 helix contacts is intriguing. In other
words, a mature T-cell alloreactive capacity is selected-for via
CDR3α that can do the R65-joint. Clearly, exceptions are 2VLR
(as discussed), and notably 3UTT, wherein CDR3β assumes the
~4Å contact with the α-2 helix, at H151. In this structure, the
closest CDR3α contact is ~5Å from Q155 (Figure 7). Thus, in
the case of 3UTT, the interface of the TCR with a.a. 151–158
polymorphic positions appears to have been directly selected-
for, i.e., the other TCR utilizes the indirect across-the-groove Vα
geometry described herein.
Conclusion
The idea that CDR2 and/or CDR1 have “co-evolved” with the
MHC with the product being conserved/predictable contacts
between them (4) has been disputed (27–29). For instance, co-
receptors have been suggested as the true selective agents (28), and
TCRhave been selected inMHCknock-outmice independently of
MHC (29). Nevertheless, CDR1/2 andMHC are clearly germ-line
encoded, and any observations of conservative interactions across
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FIGURE 5 | The CDR2α:R65:α-2 angle of representative TCR:pHLA-A2.
PDB file is denoted in far left panels and middle and right panels reflect different
views of each complex. The R65 motif is in orange and the H151-A158 region is
in yellow. Contacting CDR3α a.a., lime (3H9S), tan (2PYE), green (3HG1),
magenta (1BD2), white (3O4L), light green (3QEQ). CDR2α: pink (3H9S), silver
(2PYE), white (3HG1), white (1BD2), rose (3O4L), and white (3QEQ); cyan ribbon
alpha carbon backbones. Peptides: magenta (3H9S), foam (2PYE), tan (3HG1),
tan (1BD2), lime (3O4L), and silver (3QEQ). The R65-angle was measured with
VMD (shown as yellow trace). CDR3α:peptide contacts are shown as white
trace.
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FIGURE 6 | Estimating TCR twist/tilt/sway: (left) measuring an angle across the groove to C22/3/4 of TCR-Vα (“twist”) and perpendicular to the
groove to C22/3/4 (“tilt”); (right) measuring an angle parallel to the groove (“sway”).
TABLE 1 | Predicting the R65-angle from the orientation of TCR-Vα on pHLA-A.
PDB ω° λ° @° φmeasured k* φ

calculated
1AO7 96:12 128.94 39.48 17.93 1.26 22.53
3HG1 91:51 132.66 36.24 18.90 1.04 19.63
3O4L 89:00 141.85 29.02 17.96 0.84 15.11
2BNQ 99:35 156.54 17.81 12.23 0.83 10.15
3QEQ 93:32 135.26 34.26 13.71 1.38 18.86
3GSN 87:75 145.76 25.42 17.92 0.73 13.03
3W0W 106:80 135.92 34.28 16.30 1.32 21.51
3UTT 95:79 140.47 30.70 24.28 0.71 17.18
4QOK 103:34 131.06 37.67 19.73 1.17 23.07
4JFD 97:84 131.87 36.89 21.14 1.01 21.34
4EUP 97:32 140.30 30.35 16.80 1.03 17.31
Estimated twist/tilt/sway of the TCR (from Vα) relative to the R65-angle and calculation.
*k indicates deviation between values for φ. Mean k = 1.030.23 (s), n = 11; t = 0.43, µo =1.00; p = 0.67; thus (overall) φ values are not statistically different; 99% CI, k = 1.25–0.81;
two-tailed Student’s t-test calculator tool @ http://in-silico.net/tools/statistics/ttest. For 3UTT, the closest contact with α-2 helix is via CDR3β (K102; Figure 7), which was used to
measure the R65-angle.
“Twist” (ω): measuring the angle: T73 (α-1 helix):H151 (α-2 helix):C22/3/4 (TCR-Vα).
“Tilt” (λ): measuring the angle: S11 (β-1 stand):T73 (α-1 helix):C22/3/4 (TCR-Vα).
“Sway” (@): measuring the angle: T73 (α-1 helix):S11 (β-1 strand):C22/3/4 (TCR-Vα).
“Pitch” (φ): R65-angle (CDR2α contact a.a.:R65:α-2 helix contact a.a.), related by: kφ = [@  (λ + @)](ω).
phylogeny are indeed evidence for “co-evolution” per se; what
particular mechanism of thymic selection dictates it is still debat-
able. However, it must be considered that the somatic mechanism
of CDR3 has had to entail with MHC polymorphism for some
400My (30); and indeed, that the TCR repertoire is inherently
alloreactive (1, 11).
The analysis presented here suggests a novel structural mech-
anism for MHC control of TCR diversity, and may help explain
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FIGURE 7 | The 3UTT TCR contacts R65 via CDR3α, but contacts the α-2
helix via CDR3β. (A) Overall structure of 3UTT; orange arrow indicates unusual
(here) across-the-groove contact between CDR3β and H151 [3.70Å; bottom
right, (C)]. Note CDR3α makes “usual” R65-joint [3.02Å; upper right, (B)]. Like
2VLR, this seems an alternate strategy to the same distance of TCR contacts
with the polymorphic a.a. 151–158 subregion. In this case, the interface was
directly selected via the rearranged CDR3β; in all others, it is indirect via the
described geometry; actual frequency for these TCR strategies is not known.
the enigmatic biology of T-cell alloreactivity. Thus, somatic
CDR3α appears selected for TCR contact with allo-HLA-A by
virtue of the R65-joint geometry explained herein, manifest in
the TCR repertoire as the germline CDR2α/α-2 helix inter-
face. Seemingly unusual 3UTT, wherein the interface is appar-
ently directly selected-for via CDR3β, still utilized the R65-joint
(S95O:R65NH2, 3.02Å), and crucially maintained ~4Å contact
at the same α-2 helix position (βK102N2:H151NE2, 3.70Å).
Indeed, in both the 2VLR and 3UTT structures, TCR strategies
for maintaining contact with the α-2 helix polymorphic posi-
tions seem like exceptions to the rule. Although, to be clear, the
actual relative frequency of these different strategies within the
TCR repertoire is not known. Nevertheless, the consistent use
of the R65-joint geometry, even among these available struc-
tures, certainly hints at a rather straightforward hypothesis. Thus,
TCR with CDR3α’s yielding TCR:pHLA-A2 complexes with the
CDR2α/α-2 helix interface below or above ~4Å (exception being
3UTT-like TCR) are proposed to be theoretically not selected. That
surviving thymocytes turn out to be the best TCR bearers for pro-
tective immunity is assumed (this seems essential); what is clear,
is that part of the immune system does respond directly against
allo-HLA class I molecules for a biologically apparent reason.
Indeed,R65-joint bioinformatics (as indicated) are consistent with
the emergence of HLA-C and KIR genes (10). Maternal uNK cells
induce fetal trophoblast-mediated re-modeling of the maternal
circulation; yet, HLA-C:KIR is restricted to the higher primates
(31). The structural R65 motif in a shared prosimian ancestor
(11, 17, 18), that KIR and TCR bind to overlapping sites on pHLA-
A molecules (10); pseudogenes and orphan receptors in extant
human KIR genes (10, 31); and the balance of inflammatory/non-
inflammatory cytokines (32), all tempt speculation that the R65-
joint had/has a role in pregnancy. Finally, while several elegant
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mechanisms have been described for maintaining maternal tol-
erance against the fetal paternal allotype (31, 32); the R65-joint
might facilitate fetal CD8 T cells to “reject” infiltrating maternal
cells via the unsharedHLA-A allele, perhaps in the second or third
trimesters (33). Obviously, as gestation becamemore prolonged in
primates, alleles containing the motif could have been favored.
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